Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...

A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...

Weight loss drugs may be the answer to slowing cancer progression and a lower risk of death, according to new research, which is set to be presented this week at the American Society of Clinical Oncol ...

A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.

Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...

Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in ...